Tag: Melt Pharmaceuticals

Melt Pharmaceuticals has filed a notice of an exempt offering of securities to raise $30 Million in New Equity Investment.

Melt Pharmaceuticals has filed a notice of an exempt offering of securities to raise $30 Million in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Melt Pharmaceuticals is raising $30,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Gregory Madison played a…

Read More Read More